Essential Oil in Beta-Cyclodextrin for Solid-State Pharmaceutical Applications.

Antimicrobial resistance related to the misuse of antibiotics is a well-known current topic. Their excessive use in several fields has led to enormous selective pressure on pathogenic and commensal bacteria, driving the evolution of antimicrobial resistance genes with severe impacts on human health. Among all the possible strategies, a viable one could be the development of medical features that employ essential oils (EOs), complex natural mixtures extracted from different plant organs, rich in organic compounds showing, among others, antiseptic properties.

Extracts from Cabbage Leaves: Preliminary Results towards a "Universal" Highly-Performant Antibacterial and Antifungal Natural Mixture.

As dramatically experienced in the recent world pandemic, viral, bacterial, fungal pathogens constitute very serious concerns in the global context of human health. Regarding this issue, the World Health Organization has promoted research studies that aim to develop new strategies using natural products. Although they are often competitive with synthetic pharmaceuticales in clinical performance, they lack their critical drawbacks, i.

Chemical composition and antimycotic activity of six essential oils (cumin, fennel, manuka, sweet orange, cedar and juniper) against different spp.

are commensal yeasts, present in the alimentary tract and mucocutaneous membranes of mammals. Recently, opportunistic infections increased presenting resistances. Essential oils are mixtures of volatile compounds that may show antibacterial and antifungal effects and are important for food and pharmaceutical industry purposes.

Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug.

Nonporous silica nanoparticles with an external shell containing the 3‑aminopropyl arm (SiNP) were further decorated with alginic acid (SiNP-ALG) as a potential biocompatible delivery system for Pt antitumor agents. Such particles were coupled with the prodrug (OC‑6‑44)‑acetato(β‑alaninato)diamminedichloridoplatinum(IV), 1, through the formation of amide bonds between the pendant carboxylate groups on SiNP-ALG and the free amino group of the complex. Cytosol extracted from tumor cells was able to quickly and efficiently reduce the Pt(IV) prodrug, and produces the active metabolite cisplatin.

Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes.

Phenanthriplatin, that is, (-4-3)-diamminechlorido(phenanthridine)platinum(II) nitrate, an effective antitumor cationic Pt(II) complex, was loaded on negatively charged dextran sulfate () as a model vector for drug delivery electrostatic interactions. The free complex and the corresponding conjugate with were tested on two standard human tumor cell lines, namely, ovarian A2780 and colon HCT 116, and on several malignant pleural mesothelioma cell lines (namely, epithelioid BR95, mixed/biphasic MG06, sarcomatoid MM98, and sarcomatoid cisplatin-resistant MM98R). The results suggest that the conjugate releases the active metabolite phenanthriplatin with a biphasic fashion.

A diagnostic study on folium and orchil dyes with non-invasive and micro-destructive methods.

Folium and orchil are dyes of vegetal origin. Folium is obtained from Chrozophora tinctoria (L.) A.

Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.

The optimization of the physico-chemical properties of both Gd(III) chelates and nanocarriers is of great importance for the development of effective nanosystems for magnetic resonance imaging (MRI) applications. With this aim, macrocyclic Gd(III) chelates were selectively attached to the pendant amino groups exposed to the external surface of spheroidal mesoporous silica nanoparticles (MSNs). This was achieved by treating the metal complexes with MSNs that contained the templating surfactant molecules confined within the silica channels (hexadecyltrimethylammonium (CTA)/MSN), followed by extraction of the surfactant.

Carbon coated microshells containing nanosized Gd(III) oxidic phases for multiple bio-medical applications.

Novel sub-microsized graphitic carbon shells embedding nanometric Gd(III) oxidic phases feature thermal and chemical inertness with enhanced T2 relaxation in aqueous dispersions, thus representing potential candidates for dual diagnostic (magnetic resonance imaging) and therapeutic (neutron capture therapy) applications.